A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome / Jorge Zimbrón en European Neuropsychopharmacology, Año 2016 - Vol. 26 - No. 9 (Septiembre)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2016 - Vol. 26 - No. 9 (Septiembre) . - pp. 1353-1365 Título : A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome Tipo de documento: texto impreso Autores: Jorge Zimbrón, Autor ; Golam Mohammed Ohammed Khandaker, Autor ; Chiara Toschi, Autor Fecha de publicación: 2021 Artículo en la página: pp. 1353-1365 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Esquizofrenia, Clozapina, Síndrome metabólico, Tratamiento, Metaanálisis Resumen: Metabolic complications are commonly found in people treated with clozapine. Reviews on the management of this problem have generally drawn conclusions by grouping different types of studies involving patients treated with various different antipsychotics. Link: ./index.php?lvl=notice_display&id=26496 [artículo] A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome [texto impreso] / Jorge Zimbrón, Autor ; Golam Mohammed Ohammed Khandaker, Autor ; Chiara Toschi, Autor . - 2021 . - pp. 1353-1365. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2016 - Vol. 26 - No. 9 (Septiembre) . - pp. 1353-1365 Palabras clave: Esquizofrenia, Clozapina, Síndrome metabólico, Tratamiento, Metaanálisis Resumen: Metabolic complications are commonly found in people treated with clozapine. Reviews on the management of this problem have generally drawn conclusions by grouping different types of studies involving patients treated with various different antipsychotics. Link: ./index.php?lvl=notice_display&id=26496

---

1 (1 - 1 / 1)